Article Details

Claudin18.2, a shining star in gastric cancer, Transcenta's TST001 stands at the global forefront

Retrieved on: 2022-09-28 23:32:34

Tags for this article:

Click the tags to see associated articles and topics

Claudin18.2, a shining star in gastric cancer, Transcenta's TST001 stands at the global forefront. View article details on hiswai:

Excerpt

TST001, a humanized anti-Claudin18.2 monoclonal antibody, with higher target binding affinity and enhanced ADCC activity than other antibodies, has ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up